Clinical Trials Logo

Clinical Trial Summary

To evaluate the normalization rate of CA 19-9 of individuals with non-metastatic pancreas cancer following up to 6 months of neoadjuvant chemotherapy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Adenocarcinoma
  • Borderline Resectable Pancreatic Adenocarcinoma
  • Locally Advanced Pancreatic Adenocarcinoma
  • Untreated Resectable Pancreatic Adenocarcinoma

NCT number NCT04669197
Study type Interventional
Source HonorHealth Research Institute
Contact
Status Active, not recruiting
Phase Phase 2
Start date December 1, 2020
Completion date September 30, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05679674 - Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer N/A
Recruiting NCT04617821 - AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer Phase 3
Completed NCT03673137 - Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC Phase 2/Phase 3
Recruiting NCT04652206 - Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients. Phase 1/Phase 2
Completed NCT02394535 - Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer Phase 1
Not yet recruiting NCT06399172 - OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy
Withdrawn NCT03536182 - Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer Phase 3
Active, not recruiting NCT04395469 - FAZA PET/MRI Pancreas N/A
Active, not recruiting NCT01585805 - Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Phase 2
Recruiting NCT05607953 - Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma Phase 1
Not yet recruiting NCT06381154 - Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer Phase 2
Active, not recruiting NCT03269526 - BATs Treatment for Pancreatic Cancer, Phase Ib/II Phase 1/Phase 2
Not yet recruiting NCT06453486 - A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment Phase 2
Recruiting NCT05524090 - PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer
Completed NCT01342224 - Immunochemoradiotherapy in Patients With Pancreatic Cancer Phase 1
Completed NCT01278368 - Effect Of Preoperative Chemotherapy On Short-Term Outcome After Pancreatic Resection N/A
Recruiting NCT04172532 - Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to Radiation Therapy for Localized Pancreatic Cancer Phase 1/Phase 2
Active, not recruiting NCT04423731 - Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer
Not yet recruiting NCT06272162 - Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy N/A
Active, not recruiting NCT00669734 - Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery Phase 1